Cost–utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels

N. W.D. Lamond, C. Skedgel, D. Rayson, T. Younis

科研成果: 期刊稿件 › 文章 › 同行评审

指纹

探究 'Cost–utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases